Hematology
Polycythemia
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Polycythemia is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
2
clinical trials
Recruiting1 · 50%
Completed1 · 50%
Clinical Trials
Trial Activity
POlycythemia, Proteins and ErYthropoiesis
Recruiting·—·N/A·NCT06905106·400 enrolled
Treatment of High Altitude Polycythemia by Acetazolamide
Completed·AAssociation pour la Recherche en Physiologie de l'Environnement·Phase 4·NCT00424970·55 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)